Showing 25801 - 25810 of 27841 for "Pharmaceuticals and life sciences" with applied filters
29 March 2016 by André Figueiredo and Duarte Schmidt Lino
André Figueiredo and Duarte Schmidt Lino of PLMJ assess the M&A regulatory framework in Portugal
29 March 2016 by Ruben Brigolas and Sónia Martins Reis
Ruben Brigolas and Sónia Martins Reis of PLMJ assess the M&A regulatory framework in Angola
29 March 2016 by Omar S Bassiouny and Muhammad Nassef
Omar S Bassiouny and Muhammad Nassef of Matouk Bassiouny assess the M&A regulatory framework in Egypt
29 March 2016 by Olivier Clevenbergh, Gisèle Rosselle and Thomas Pouppez
Olivier Clevenbergh, Gisèle Rosselle and Thomas Pouppez of Strelia assess the M&A regulatory framework in Belgium
29 March 2016 by Italo De Santis and Andrea Sacco Ginevri
Italo De Santis and Andrea Sacco Ginevri of Chiomenti assess the M&A regulatory framework in Italy
29 March 2016 by Folake Elias Adebowale, Mary Ekemezie and Olamide Omolaja
Folake Elias Adebowale, Mary Ekemezie and Olamide Omolaja of Udo Udoma & Belo-Osagie assess the M&A regulatory framework in Nigeria
29 March 2016 by John Cunha
John Cunha of ASAR - Al Ruwayeh & Partners assesses the M&A regulatory framework in Kuwait
29 March 2016 by Samir Abdelly
Samir Abdelly of Abdelly & Associés assesses the M&A regulatory framework in Tunisia
21 March 2016 by Bär & Karrer
BRIEFING, Zurich, 21 March, 2016
10 March 2016 by Binder Grösswang
PRESS RELEASE, Vienna, 10 March 2016